Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Elastic
ESTC
|
$348M |
| 2 |
Mercado Libre
MELI
|
$296M |
| 3 |
Nu Holdings
NU
|
$254M |
| 4 |
Roblox
RBLX
|
$219M |
| 5 |
Shopify
SHOP
|
$201M |
Top Sells
| 1 |
Albemarle
ALB
|
$185M |
| 2 |
Illumina
ILMN
|
$176M |
| 3 |
Li Auto
LI
|
$162M |
| 4 |
Trade Desk
TTD
|
$145M |
| 5 |
Ferrari
RACE
|
$138M |
Sector Composition
| 1 | Consumer Discretionary | 29% |
| 2 | Healthcare | 24.31% |
| 3 | Technology | 17.32% |
| 4 | Communication Services | 11.22% |
| 5 | Financials | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Service Corp International
SCI
$11B
| $1B | 1.04% |
17,395,963
-492,200
| -3% | -$28.4M |
|
27
BioNTech
BNTX
$24.9B
| $977M | 1.01% |
7,245,072
-17,908
| -0.2% | -$2.42M |
|
28
Meta Platforms (Facebook)
META
$1.88T
| $957M | 0.99% |
7,055,938
-97,536
| -1% | -$13.2M |
|
29
Sea Limited
SE
$112B
| $937M | 0.97% |
16,718,061
-201,716
| -1% | -$11.3M |
|
30
CoStar Group
CSGP
$37.7B
| $901M | 0.93% |
12,934,361
-223,511
| -2% | -$15.6M |
|
|
ABMD
31
DELISTED
Abiomed Inc
ABMD
| $891M | 0.92% |
3,624,937
-84,884
| -2% | -$20.9M |
|
|
32
Albemarle
ALB
$9.33B
| $850M | 0.88% |
3,215,017
-701,352
| -18% | -$185M |
|
33
Snowflake
SNOW
$74B
| $796M | 0.82% |
4,681,203
+260,269
| +6% | +$44.2M |
|
34
Mastercard
MA
$538B
| $789M | 0.81% |
2,776,120
-83,577
| -3% | -$23.8M |
|
35
Intuitive Surgical
ISRG
$163B
| $787M | 0.81% |
4,199,142
+6,926
| +0.2% | +$1.3M |
|
36
Petrobras
PBR
$79.8B
| $760M | 0.78% |
61,626,763
-1,871,016
| -3% | -$23.1M |
|
|
37
Roblox
RBLX
$90B
| $749M | 0.77% |
20,906,989
+6,123,973
| +41% | +$219M |
|
38
Royalty Pharma
RPRX
$16B
| $718M | 0.74% |
17,868,175
-126,743
| -0.7% | -$5.09M |
|
39
Thermo Fisher Scientific
TMO
$185B
| $678M | 0.7% |
1,337,727
-28,448
| -2% | -$14.4M |
|
40
NovoCure
NVCR
$1.34B
| $677M | 0.7% |
8,914,191
-202,039
| -2% | -$15.4M |
|
41
Ginkgo Bioworks
DNA
$691M
| $637M | 0.66% |
5,101,921
-31,274
| -0.6% | -$3.9M |
|
42
WIX.com
WIX
$8.19B
| $636M | 0.66% |
8,133,640
+41,723
| +0.5% | +$3.26M |
|
43
Zoom
ZM
$24.8B
| $623M | 0.64% |
8,466,914
+929,812
| +12% | +$68.4M |
|
44
Charles Schwab
SCHW
$177B
| $620M | 0.64% |
8,627,291
-248,347
| -3% | -$17.8M |
|
45
Estee Lauder
EL
$31.5B
| $582M | 0.6% |
2,695,055
-66,354
| -2% | -$14.3M |
|
46
Ryanair
RYAAY
$32B
| $559M | 0.58% |
23,918,338
-295,542
| -1% | -$6.91M |
|
47
Watsco
WSO
$16.4B
| $557M | 0.57% |
2,165,122
-6,791
| -0.3% | -$1.75M |
|
48
Datadog
DDOG
$46B
| $525M | 0.54% |
5,913,936
-154,914
| -3% | -$13.8M |
|
49
TSMC
TSM
$1.22T
| $524M | 0.54% |
7,636,884
-305,422
| -4% | -$20.9M |
|
50
Broadridge
BR
$29.5B
| $522M | 0.54% |
3,618,585
-49,872
| -1% | -$7.2M |
|